Guillaume Bassez Selected Research

Glycogen Storage Disease Type II (Pompe's Disease)

1/2023	Hypersensitivity infusion-associated reactions induced by enzyme replacement therapy in a cohort of patients with late-onset Pompe disease: An experience from the French Pompe Registry.
9/2003	Evaluation of muscle glycogen content by 13C NMR spectroscopy in adult-onset acid maltase deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guillaume Bassez Research Topics

Disease

21	Myotonic Dystrophy (Dystrophia Myotonica) 04/2024 - 10/2003
5	Muscular Diseases (Myopathy) 01/2020 - 05/2006
4	Dysferlinopathy 01/2021 - 08/2005
3	Myotonia 04/2024 - 11/2007
3	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2023 - 01/2021
3	Atrophy 01/2020 - 09/2004
3	Muscular Dystrophies (Muscular Dystrophy) 06/2017 - 08/2007
2	Glycogen Storage Disease Type II (Pompe's Disease) 01/2023 - 09/2003
2	Cardiomyopathies (Cardiomyopathy) 01/2021 - 01/2020
2	Distal Myopathies (Distal Muscular Dystrophy) 01/2020 - 03/2014
2	Weight Loss (Weight Reduction) 01/2019 - 10/2018
2	Fatigue 01/2018 - 01/2018
2	Muscle Weakness 01/2018 - 06/2017
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2018 - 05/2003
2	Dermatomyositis (Dermatopolymyositis) 01/2018 - 10/2014
2	Macrophagic myofasciitis 11/2013 - 05/2003
2	Protein Deficiency 02/2009 - 08/2007
2	Miyoshi myopathy 02/2009 - 08/2005
2	type 2B Limb-girdle muscular dystrophy 02/2009 - 08/2005
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Left Ventricular Dysfunction 01/2023
1	Hypersensitivity (Allergy) 01/2023
1	Immediate Hypersensitivity 01/2023
1	Myasthenia Gravis 01/2023
1	Camptocormia 01/2021
1	Myofibrillar Myopathy 01/2020
1	Nemaline Myopathies (Nemaline Myopathy) 01/2020
1	Brody myopathy 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 11/2019
1	Insulin Resistance 10/2018
1	Disease Progression 01/2018
1	Hearing Loss (Hearing Impairment) 01/2018
1	Pain (Aches) 01/2018
1	Body Weight (Weight, Body) 06/2017
1	Atrial Flutter (Flutter, Atrial) 03/2016
1	Neutral Lipid Storage Disease with Myopathy 02/2013
1	Neuromuscular Diseases (Neuromuscular Disease) 07/2008
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 05/2006
1	Paralysis (Palsy) 06/2005
1	Myotonic Disorders (Paramyotonia Congenita) 09/2004

Drug/Important Bio-Agent (IBA)

4	3' Untranslated Regions (3' UTR)IBA 06/2017 - 10/2003
4	DysferlinIBA 02/2009 - 08/2005
3	GlycogenIBA 01/2023 - 09/2003
3	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021 - 08/2007
3	Biomarkers (Surrogate Marker)IBA 11/2019 - 10/2014
3	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 11/2015
3	RNA (Ribonucleic Acid)IBA 01/2018 - 06/2011
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2021
2	Antisense OligonucleotidesIBA 11/2019 - 06/2017
2	milk-derived factorIBA 08/2019 - 12/2018
2	Protein Isoforms (Isoforms)IBA 03/2014 - 09/2004
1	Mexiletine (Mexitil)FDA LinkGeneric 04/2024
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2023
1	FilaminsIBA 01/2020
1	CalciumIBA 01/2020
1	OligonucleotidesIBA 11/2019
1	Peptides (Polypeptides)IBA 11/2019
1	AutoantibodiesIBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 01/2018
1	AntibodiesIBA 01/2018
1	ISIS 486178IBA 06/2017
1	Protein Kinases (Protein Kinase)IBA 06/2017
1	HLA-DR Antigens (HLA-DR)IBA 10/2014
1	Ligases (Synthetase)IBA 10/2014
1	Histocompatibility Antigens Class IIIBA 10/2014
1	Messenger RNA (mRNA)IBA 03/2014
1	AluminumIBA 11/2013
1	VaccinesIBA 11/2013
1	Synapsins (Synapsin I)IBA 03/2013
1	Proteins (Proteins, Gene)FDA Link 03/2013
1	Lipase (Acid Lipase)FDA Link 02/2013
1	Triglycerides (Triacylglycerol)IBA 02/2013
1	Myotonin-Protein KinaseIBA 01/2012
1	GuanineIBA 11/2007
1	ThymineIBA 11/2007
1	CytosineIBA 11/2007
1	Lamin Type A (Lamin A)IBA 05/2006
1	Calcium Channels (Calcium Channel)IBA 06/2005
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 09/2004
1	tau Proteins (tau Protein)IBA 09/2004
1	Aluminum Hydroxide (Algeldrate)FDA Link 05/2003

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2018
2	Activities of Daily Living (ADL) 01/2023 - 01/2018
1	Enzyme Replacement Therapy 01/2023
1	Premedication 01/2023
1	Artificial Respiration (Mechanical Ventilation) 01/2023
1	Hearing Aids (Hearing Aid) 01/2018
1	Exercise Therapy (Therapy, Exercise) 01/2018
1	Radiofrequency Ablation 03/2016
1	Denervation 04/2008